pfizer glp 1 oral Pfizer's Appetite for More Obesity Meds Leads to $150M Deal for GLP-1 Drug From China Pfizer Discontinues Development of Investigational

Any dust or microbes in the environment can compromise your sample

Future Science OA , 4(2), FSO272

Among these, kynurenine (OR = 1.441, 95%CI = 1.0891.906, p-value = 0.018) and 1-stearoyl-GPE (18:0) (OR = 1.263, 95%CI = 1.0291.550, p-value = 0.029) were identified as risk factors for myocarditis, while deoxycarnitine (OR = 0.813, 95%CI = 0.6760.979, p-value = 0.029), 5-acetylamino-6-formylamino-3-methyluracil (OR = 0.864, 95% CI = 0.7750.962, p-value = 0.018), and X-25,422 (OR = 0.721, 95%CI = 0.5870.886, p-value = 0.009) were found to be protective factors

L Lv and J Yao participated in western blotting and immunofluorescence staining

Long session